Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Intramuscular Injection of Adenoassociated Virus Encoding Human Neurotrophic Factor 3 and Exercise Intervention Contribute to Reduce Spasms after Spinal Cord Injury

Intramuscular Injection of Adenoassociated Virus Encoding Human Neurotrophic Factor 3 and Exercise Intervention Contribute to Reduce Spasms after Spinal Cord Injury

Neural Plasticity, 2019 · DOI: https://doi.org/10.1155/2019/3017678 · Published: March 11, 2019

Spinal Cord InjuryGeneticsRehabilitation

Simple Explanation

Limb spasms are common after spinal cord injury, and current treatments aren't ideal. This study explores a combination of gene therapy and exercise to reduce these spasms. Rats with spinal cord injuries received gene therapy (AAV-NT3) and a 2-week exercise program. Researchers then measured spasm frequency, H-reflex, motor function, and neuron characteristics. The study found that the combination therapy reduced spasms and improved motor neuron protection. It suggests that combining gene therapy and exercise can alleviate muscle spasms by influencing spinal cord neurons.

Study Duration
6 weeks
Participants
Ninety female Wistar rats
Evidence Level
Not specified

Key Findings

  • 1
    AAV-NT3 gene therapy, exercise, and combination therapy all reduced spasm frequency at 6 weeks after spinal cord injury.
  • 2
    Combination therapy was significantly better than AAV-NT3 alone in protecting motor neurons after spinal cord injury.
  • 3
    Combination therapy resulted in greater recovery of KCC2 expression compared to exercise alone, and was superior in remodeling spinal cord neurons.

Research Summary

This study investigates a combination therapy of AAV-NT3 gene therapy and exercise to reduce muscle spasms after spinal cord injury in rats. The results indicate that AAV-NT3 gene therapy, exercise, and the combination of both can alleviate muscle spasms after spinal cord injury. The combination therapy rebalances excitatory and inhibitory networks in the spinal cord, normalizing monosynaptic and multiple synaptic reflexes.

Practical Implications

Rehabilitation Strategies

Combining gene therapy with exercise may offer a more effective approach to managing spasticity and improving motor function in spinal cord injury patients.

Therapeutic Target

NT-3, delivered via gene therapy, combined with exercise, has potential to restore the balance of excitation and inhibition in the spinal cord, reducing spasticity.

Clinical Trials

Further research is needed to optimize the timing and intensity of combined therapies to maximize their beneficial effects on muscle spasms and motor recovery.

Study Limitations

  • 1
    Combination therapy did not show a significant additive effect, suggesting the need to improve the combined strategy.
  • 2
    Severe spinal cord contusion surgery prevented most rats from walking upright after 4 weeks of spinal cord injury.
  • 3
    The time point and duration of each individual therapy may have impacted the results.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury